Aire Advisors, LLC Immunity Bio, Inc. Transaction History
Aire Advisors, LLC
- $513 Million
- Q3 2025
A detailed history of Aire Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Aire Advisors, LLC holds 20,068 shares of IBRX stock, worth $41,741. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,068
Previous 16,768
19.68%
Holding current value
$41,741
Previous $44,000
11.36%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IBRX
# of Institutions
299Shares Held
137MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...